Tumor angiogenesis and biologic markers in resected stage I NSCLC
Author:
Open Access
- 1 October 1997
- journal article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 12 (4) , 535-541
Abstract
OBJECTIVE: Microvessel count (MC), as a measure of tumor angiogenesis, has been shown to be significantly correlated with metastatic disease incutaneKeywords
This publication has 26 references indexed in Scilit:
- Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (Stage IIIA-N2): Impact of adjuvant therapies in a subset of patients at high risk of recurrenceCancer, 1996
- Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancerThe Annals of Thoracic Surgery, 1996
- Microvessel count predicts metastatic disease and survival in non‐small cell lung cancerThe Journal of Pathology, 1995
- The implications of angiogenesis for the biology and therapy of cancer metastasisCell, 1994
- Intratumoral microvessel density and L53 protein: Correlation with metastasis in head‐and‐neck squamous‐cell carcinomaInternational Journal of Cancer, 1993
- Postoperative Chemotherapy for Non-Small-Cell Lung CancerChest, 1993
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI: Journal of the National Cancer Institute, 1990
- Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.Journal of Clinical Oncology, 1984
- Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study GroupCancer, 1984
- Tumor Behavior in Isolated Perfused OrgansAnnals of Surgery, 1966